Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Berry

Showing results (51-60 of 311) with videos related to

Pageof 32
Sort By:
Journal of Autism and Developmental Disorders|March 14, 2026
Discourse Marker Use in Mothers of Autistic Individuals and FMR1 Premutation CarriersNell Maltman, Gary E Martin, Jamie Barstein, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|March 27, 2020
TECPR2 mutation-associated respiratory dysregulation: more than central apneaPallavi P Patwari, Lisa F Wolfe, Girish D Sharma, et al.
Annals of Neurology|December 29, 2004
Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivationElizabeth Berry-Kravis, Kristina Potanos, Dahlia Weinberg, et al.
Brain and Cognition|December 31, 2019
Inhibition deficits are modulated by age and CGG repeat length in carriers of the FMR1 premutation allele who are mothers of children with fragile X syndromeJessica Klusek, Jinkuk Hong, Audra Sterling, et al.
Clinical Parkinsonism & Related Disorders|April 20, 2026
Essential tremor-like phenotype in Fragile X carrier womenDeborah A Hall, Danuta Loesch, Tyler Svymbersky, et al.
ACS Chemical Neuroscience|December 8, 2022
Emerging Therapeutic Strategies for Fragile X Syndrome: Q&AGhassan Alusi, Elizabeth Berry-Kravis, David Nelson, et al.
Journal of Inherited Metabolic Disease|August 15, 2025
Biomarker Validation in NPC1: Foundations for Clinical Trials and Regulatory AlignmentKrista Casazza, Stephanie M Cologna, Elizabeth Berry-Kravis, et al.
Archives of Neurology|August 18, 2004
Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin systemJennifer G Goldman, Christopher G Goetz, Elizabeth Berry-Kravis, et al.
The Veterinary Record|October 28, 2017
Benchmarking antimicrobial useFiona Lovatt, Christian Blake-Dyke, Elizabeth Berry, et al.
Journal of Neurodevelopmental Disorders|March 27, 2026
Electroretinography biomarkers indicate disrupted visual processing in Fragile X syndromeQianyi Pu, Naomi Bennett, Tejas C Sekhar, et al.
Pageof 32

Showing results (51-60 of 311) with videos related to

Sort By:
Pageof 32
Journal of Autism and Developmental Disorders|March 14, 2026
Discourse Marker Use in Mothers of Autistic Individuals and FMR1 Premutation CarriersNell Maltman, Gary E Martin, Jamie Barstein, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|March 27, 2020
TECPR2 mutation-associated respiratory dysregulation: more than central apneaPallavi P Patwari, Lisa F Wolfe, Girish D Sharma, et al.
Annals of Neurology|December 29, 2004
Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivationElizabeth Berry-Kravis, Kristina Potanos, Dahlia Weinberg, et al.
Brain and Cognition|December 31, 2019
Inhibition deficits are modulated by age and CGG repeat length in carriers of the FMR1 premutation allele who are mothers of children with fragile X syndromeJessica Klusek, Jinkuk Hong, Audra Sterling, et al.
Clinical Parkinsonism & Related Disorders|April 20, 2026
Essential tremor-like phenotype in Fragile X carrier womenDeborah A Hall, Danuta Loesch, Tyler Svymbersky, et al.
ACS Chemical Neuroscience|December 8, 2022
Emerging Therapeutic Strategies for Fragile X Syndrome: Q&AGhassan Alusi, Elizabeth Berry-Kravis, David Nelson, et al.
Journal of Inherited Metabolic Disease|August 15, 2025
Biomarker Validation in NPC1: Foundations for Clinical Trials and Regulatory AlignmentKrista Casazza, Stephanie M Cologna, Elizabeth Berry-Kravis, et al.
Archives of Neurology|August 18, 2004
Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin systemJennifer G Goldman, Christopher G Goetz, Elizabeth Berry-Kravis, et al.
The Veterinary Record|October 28, 2017
Benchmarking antimicrobial useFiona Lovatt, Christian Blake-Dyke, Elizabeth Berry, et al.
Journal of Neurodevelopmental Disorders|March 27, 2026
Electroretinography biomarkers indicate disrupted visual processing in Fragile X syndromeQianyi Pu, Naomi Bennett, Tejas C Sekhar, et al.
Pageof 32